Cargando…

Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist

The physiologic properties of glucagon-like peptide 1 (GLP-1) make it a potent candidate drug target in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 is capable of regulating the blood glucose level by insulin secretion after administration of oral glucose. The advantages of GLP-1 for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying, Zheng, Xuemin, Yi, Xiulin, Liu, Changxiao, Kong, Dexin, Zhang, Jianning, Gong, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of American Societies for Experimental Biology 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434659/ https://www.ncbi.nlm.nih.gov/pubmed/28270518 http://dx.doi.org/10.1096/fj.201601339R

Ejemplares similares

Myricetin, a potent natural agent for treatment of diabetic skin damage by modulating TIMP/MMPs balance and oxidative stress
por: Wu, Zijian, et al.
Publicado: (2016)

Class B1 GPCR activation by an intracellular agonist
por: Kobayashi, Kazuhiro, et al.
Publicado: (2023)

pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
por: Velloso, João Paulo L, et al.
Publicado: (2021)

Baicalein, 7,8-Dihydroxyflavone and Myricetin as Potent Inhibitors of Human Ornithine Decarboxylase
por: Liu, Yun-Chin, et al.
Publicado: (2020)

Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics
por: Hua, Dan, et al.
Publicado: (2014)

Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
por: Colom, Matthieu, et al.
Publicado: (2019)

Variant fatty acid-like molecules Conjugation, novel approaches for extending the stability of therapeutic peptides
por: Li, Ying, et al.
Publicado: (2015)

GPCR activation mechanisms across classes and macro/microscales
por: Hauser, Alexander S., et al.
Publicado: (2021)

Class A and C GPCR Dimers in Neurodegenerative Diseases
por: Caniceiro, Ana B., et al.
Publicado: (2022)

The Class-A GPCR Dopamine D2 Receptor Forms Transient Dimers Stabilized by Agonists: Detection by Single-Molecule Tracking
por: Kasai, Rinshi S., et al.
Publicado: (2017)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

Effect of Myricetin on Primary Open-angle Glaucoma
por: Yang, Qing, et al.
Publicado: (2018)

Myricetin Improves Impaired Nerve Functions in Experimental Diabetic Rats
por: Ma, Junxiong, et al.
Publicado: (2022)

Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APC(Min/+) mice
por: Li, Ye, et al.
Publicado: (2016)

Natural Flavonol, Myricetin, Enhances the Function and Survival of Cryopreserved Hepatocytes In Vitro and In Vivo
por: Cui, Changhao, et al.
Publicado: (2019)

Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies
por: Scott, Martin J., et al.
Publicado: (2020)

Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus
por: Niisato, Naomi, et al.
Publicado: (2023)

Myricetin: a Multifunctional Flavonol in Biomedicine
por: Agraharam, Gopikrishna, et al.
Publicado: (2022)

Regioselective Synthesis of Quercetin and Myricetin Derivatives
por: Pechinskii, S. V., et al.
Publicado: (2023)

Coordination-assembled myricetin nanoarchitectonics for sustainably scavenging free radicals
por: Ma, Xiaoyan, et al.
Publicado: (2022)

Machine Learning to Identify Flexibility Signatures of Class A GPCR Inhibition
por: Bemister-Buffington, Joseph, et al.
Publicado: (2020)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

Activation mechanism of the class D fungal GPCR dimer Ste2
por: Velazhahan, Vaithish, et al.
Publicado: (2022)

A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists
por: Sheth, Heeral, et al.
Publicado: (2013)

Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide
por: Huang, Changjiang, et al.
Publicado: (2016)

Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach
por: Akash, Shopnil, et al.
Publicado: (2022)

Correction: Coordination-assembled myricetin nanoarchitectonics for sustainably scavenging free radicals
por: Ma, Xiaoyan, et al.
Publicado: (2022)

Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma
por: Li, Ying, et al.
Publicado: (2016)

Inhibitory Effects of Myricetin on Lipopolysaccharide-Induced Neuroinflammation
por: Jang, Jung-Hee, et al.
Publicado: (2020)

A Natural Dietary Flavone Myricetin as an α-Hemolysin Inhibitor for Controlling Staphylococcus aureus Infection
por: Wang, Tingting, et al.
Publicado: (2020)

The VPAC1 receptor: structure and function of a class B GPCR prototype
por: Couvineau, A., et al.
Publicado: (2012)

Stepwise activation of a class C GPCR begins with millisecond dimer rearrangement
por: Grushevskyi, Eugene O., et al.
Publicado: (2019)

Comparative Analysis of Radical Adduct Formation (RAF) Products and Antioxidant Pathways between Myricetin-3-O-Galactoside and Myricetin Aglycone
por: Li, Xican, et al.
Publicado: (2019)

Synthesis and physicochemical characterization of acyl myricetins as potential anti-neuroexocytotic agents
por: Cho, Sora, et al.
Publicado: (2023)

Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist
por: Chan, John D., et al.
Publicado: (2016)

Novel Structural Approaches to Study GPCR Regulation
por: Alfonzo-Méndez, Marco A., et al.
Publicado: (2016)

Editorial: New approaches for the discovery of GPCR ligands
por: Morales, Paula, et al.
Publicado: (2023)

Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation
por: Bruzzese, Agustín, et al.
Publicado: (2020)

G12/13 is activated by acute tethered agonist exposure in the adhesion GPCR ADGRL3
por: Mathiasen, Signe, et al.
Publicado: (2020)

Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
por: Cao, Anne-Marinette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cc54up63tbkdqgjsclm5ofudrr